发明名称 |
Composition for nasal administration and method for preparing same |
摘要 |
The invention provides a powdered composition for nasal administration, comprising a physiologically active peptide and cellulose acetate as the base, and having excellent nasal absorption for physiologically active peptides. |
申请公布号 |
US8802622(B2) |
申请公布日期 |
2014.08.12 |
申请号 |
US201113635580 |
申请日期 |
2011.03.18 |
申请人 |
Daiichi Sankyo Company, Limited |
发明人 |
Matsumoto Masaru;Takeda Shuji;Nobori Kyohei |
分类号 |
A61K38/02;A61K9/14;A61K47/38;A61K38/22;A61K38/26;A61K38/29;A61K9/00;A61K38/25;A61K9/16;A61K9/48 |
主分类号 |
A61K38/02 |
代理机构 |
Drinker Biddle & Reath LLP |
代理人 |
Drinker Biddle & Reath LLP |
主权项 |
1. A powdered composition for nasal administration comprising a physiologically active peptide and cellulose acetate as a base, wherein the composition is obtained by 1) mixing the physiologically active peptide, cellulose acetate and at least 20 wt % of water with respect to the cellulose acetate, and 2) drying the mixture,
wherein the physiologically active peptide is human glucagon-like peptide-1, human parathyroid hormone (hPTH), hPTH (1-34), human motilin, a human motilin derivative consisting of the amino acid sequence of SEQ ID NO: 1, human ghrelin, human atrial natriuretic peptide, brain natriuretic peptide (BNP) or C-type natriurectic peptide (CNP). |
地址 |
Chuo-ku, Tokyo JP |